Characterization of patients with recurrent ischaemic stroke using the ASCO classification

European Journal of Neurology

Volumn 20, Issue 5, 2013, Pages 812-817

  Wolf, M E ^a   Sauer, T ^a   Hennerici, M G ^a   Chatzikonstantinou, A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Classification systems; Stroke; Subtype

Indexed keywords

ADULT; AGED; ARTICLE; ASCO SCORE; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84876344703     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12068     Document Type: Article

References (19)

1. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis 2009; 27: 502-508.
2. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. [Clinical Trial Multicenter Study Randomized Controlled Trial Research Support, U.S. Gov't, P.H.S.]. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
3. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. Classification of stroke subtypes. [Review]. Cerebrovasc Dis 2009; 27: 493-501.
4. Wolf ME, Sauer T, Alonso A, Hennerici MG. Comparison of the new ASCO classification with the TOAST classification in a population with acute ischemic stroke. J Neurol 2012; 259: 1284-1289.
5. Elneihoum AM, Goransson M, Falke P, Janzon L. Three-year survival and recurrence after stroke in Malmo, Sweden: an analysis of stroke registry data. [Research Support, Non-U.S. Gov't]. Stroke 1998; 29: 2114-2117.
6. Hankey GJ, Jamrozik K, Broadhurst RJ, et al. Long-term risk of first recurrent stroke in the Perth Community Stroke Study. [Research Support, Non-U.S. Gov't]. Stroke 1998; 29: 2491-2500.
7. Hillen T, Coshall C, Tilling K, Rudd AG, McGovern R, Wolfe CD. Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcomes of stroke recurrence in the South London Stroke Register. [Research Support, Non-U.S. Gov't]. Stroke 2003; 34: 1457-1463.
8. Sacco RL, Shi T, Zamanillo MC, Kargman DE. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. [Research Support, U.S. Gov't, P.H.S.]. Neurology 1994; 44: 626-634.
9. Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. [Comparative StudyResearch Support, Non-U.S. Gov't]. Stroke 1994; 25: 333-337.
10. Mono ML, Geister L, Galimanis A, et al. Patent foramen ovale may be causal for the first stroke but unrelated to subsequent ischemic events. Stroke 2011; 42: 2891-2895.
11. Ballotta E, Da Giau G, Meneghetti G, Barbon B, Militello C, Baracchini C. Progression of atherosclerosis in asymptomatic carotid arteries after contralateral endarterectomy: a 10-year prospective study. J Vasc Surg 2007; 45: 516-522.
12. Fluri F, Engelter ST, Wasner M, Stierli P, Merlo A, Lyrer PA. The probability of restenosis, contralateral disease progression, and late neurologic events following carotid endarterectomy: a long-term follow-up study. [Research Support, Non-U.S. Gov't]. Cerebrovasc Dis 2008; 26: 654-658.
13. Ay H, Oliveira-Filho J, Buonanno FS, et al. Diffusion-weighted imaging identifies a subset of lacunar infarction associated with embolic source. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. Stroke 1999; 30: 2644-2650.
14. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. JAMA 2001; 285: 2370-2375.
15. Hylek EM, Go AS, Chang Y, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. N Engl J Med 2003; 349: 1019-1026.
16. Wallentin L, Yusuf S, Ezekowitz MD, et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. [Comparative Study Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't]. Lancet 2010; 376: 975-983.
17. Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-891.
18. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. [Comparative Study Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. Stroke 2000; 31: 1062-1068.
19. Lees KR. Multifactorial approach to stroke investigation and prevention. Lancet 1998; 352: 923-924.